BECKMAN COULTER LIFE SCIENCES LAUNCHES NEXT-GENERATION BIOLECTOR XT MICROBIOREACTOR
m2p-labs, BioLector family of products acquired by Beckman Coulter Life Sciences in 2020
BAESWEILER, GERMANY (May 25, 2021) – Microbioreactor technology is accelerating and increasing automation capabilities with the launch of the new...
Read moreBECKMAN COULTER LIFE SCIENCES ACQUIRES MICROBIOREACTOR MANUFACTURER M2P-LABS
(INDIANAPOLIS, INDIANA – November 12, 2020)
Beckman Coulter Life Sciences signed a definitive agreement to acquire m2p-labs, a privately held, microbioreactor manufacturer based in Baesweiler,...
Read moreThe U.S. government will pay as much as $1.5 billion to buy 100 million doses of Moderna's experimental coronavirus vaccine, securing supplies of a...
Read morePress Clip - Instant caRNA? Tesla touts RNA bioreactor it is developing with Curevac
BioProcess International
Curevac and car maker Tesla claim their development RNA production tech is less labour intensive and more deployable than alternatives.
Read more
Press Clip - Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to Support
The Motley Fool
The Trump administration has picked five COVID-19 vaccine candidates that it views as the most likely to be successful, according to an article...
Read morePress Clip - Moderna Coronavirus Vaccine Trial Shows Promising Early Results
The New York Times
The company said a test in 8 healthy volunteers found its experimental vaccine was safe and provoked a strong immune response. It is on an accelerated...
Read more